BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  In2Bones Launches CoLink Vallux™ Active Bunion Procedure

  In2Bones Global, Inc. announces the commercial launch of the CoLink Vallux™ Active Bunion, a new, minimally invasive, joint-sparing correction technique for moderate to severe bunions.

  March 8, 2022

   · 

  6 min read
• Business

  Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

  Voyager Therapeutics, Inc., a gene therapy company developing life-changing treatments and next-generation adeno-associated virus capsids, reported fourth quarter and full year 2021 financial and operating results.

  March 8, 2022

   · 

  17 min read
• Business

  MiroBio Continues Expansion of Executive Leadership Team with Key Appointments to Advance Development of Checkpoint Agonist Antibodies for Autoimmune Disease

  MiroBio, a biotechnology company advancing checkpoint agonist therapies to restore immune balance, announced two key additions to its leadership team.

  March 8, 2022

   · 

  4 min read
• Business

  Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

  Matinas BioPharma Holdings, Inc. reported financial results for the fourth quarter and full year ended December 31, 2021, along with a corporate update.

  March 8, 2022

   · 

  12 min read
• Business

  Entera Bio Reports Financial Results for the Year Ended December 31, 2021

  Entera Bio Ltd., a leader in the development of orally delivered large molecule therapeutics, announced financial and operating results for the year ended December 31, 2021, and provided an update on its clinical and pre-clinical programs.

  March 8, 2022

   · 

  13 min read
• Pharm Country

  Immunic, Inc. to Participate in Investor and Scientific Conferences in March 2022

  Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced participation in the following investor and scientific conferences in March:

  March 8, 2022

   · 

  4 min read
• Drug Development

  Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBD

  Health Canada approved the amendment of the phase I study to assess the effect of low and moderate doses of inhaled CBD in healthy cannabinoid users.

  March 8, 2022

   · 

  6 min read
• Avivagen Secures New Influential Customer in Mexico

  The sale follows a successful customer evaluation trial confirming that OxC-betaTM Livestock increased productivity, flock health, uniformity and improved skin pigmentation within its operations.

  March 8, 2022

   · 

  5 min read
• RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission

  Rapid Dose Therapeutics Corp. along with their UK and European partner RD Therapeutics, proudly supports the #100DaysMission.

  March 8, 2022

   · 

  5 min read
• Business

  Stevanato Group Reports Record 2021 Revenue of €843.9 million

  Stevanato Group S.p.A. today announced its financial results for the fourth quarter 2021.

  March 8, 2022

   · 

  22 min read